Dosage Form: Oil solution for Injection
Pharmacotherapeutic group: Androgens. ATC code G03BA03.
Androgenic substance, contains a testosterone ester like enanthate. Depending on the metabolic and hormonal levels, the average period of effectiveness is 2-3 weeks. It affects the development and function of the external genitalia, prostate, seminal vesicles, and secondary sexual characteristics (voice, hair growth). Participates in the formation of the constitution of the body and sexual behavior, stimulates the libido and potency, stimulates spermatogenesis. Is an antagonist of female sex hormones – estrogen. Has anabolic effect which manifests itself in stimulating protein synthesis, the delay required for the synthesis of protein, potassium, sulfur, phosphorus, strengthes the fixation of calcium in the bones and increases lean body mass. With sufficient protein diet stimulates erythropoietin production.
Indications for REFERENCE:
Replacement therapy in primary and secondary hypogonadism, eunuchoidism; impotence endocrine genesis, post-castration syndrome; male menopause; oligospermia; osteoporosis caused by androgen deficiency. Hormone-dependent tumors in women – breast cancer and menopausal disorders in women (with estrogen) and functional bleeding Hyperestrogenism; uterine fibroids.